-Siegfried

Background

Listed on the Swiss Exchange, Siegfried Group was established in 1873 as a world-class pharmaceutical company integrating R&D and production. It supplies active   pharmaceutical ingredients (APIs) and finished dosage forms to internationally renowned companies such as Novartis, Pfizer, and Lilly.

The group operates 13 manufacturing facilities across Switzerland, Germany, France, the United States, and China. In 2024, its sales reached approximately CHF 1.3 billion. Its Nantong facility, located in BioSpark, is Siegfried’s only production site in the Asia-Pacific region and the Eastern Hemisphere.

Case details

• Total Investment: USD 131 million

• Site Area: 82,000 ㎡

• Construction Area: 35,345 ㎡